Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine

Neuropsychopharmacology

Volumn 33, Issue 3, 2008, Pages 627-633

  Tanabe, Jody ^a,d   Crowley, Thomas ^a   Hutchison, Kent ^b   Miller, David ^a   Johnson, Glyn ^c   Du, Yiping P ^a   Zerbe, Gary ^a   Freedman, Robert ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Cerebral blood flow; Nicotine; Subjective withdrawal; Ventral striatum

Indexed keywords

NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; BRAIN CIRCULATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

ADULT; ALGORITHMS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; CHEWING GUM; FEMALE; HEART RATE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEOSTRIATUM; NICOTINE; NICOTINIC AGONISTS; QUESTIONNAIRES; SEX CHARACTERISTICS; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; THALAMUS;

EID: 38149030100     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301428     Document Type: Article

References (39)

1. Benowitz NL (1988). Pharmacologic aspect of cigarette smoking and nicotine addiction. N Engl J Med 319: 1318-1339.
2. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004). Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211-1218.
3. Carroll TJ, Rowley HA, Haughton VM (2003). Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 227: 593-600.
4. CDC (2005). Morbidity and Mortality Weekly Report. Department of Health and Human Services (ed).
5. Colby SM, Tiffany ST, Shiffman S, Niaura RS (2000). Measuring nicotine dependence among youth: a review of available approaches and instruments. Drug Alcohol Depend 59(Suppl 1): S23-S39.
6. Cole JWL, Grizzle JE (1966). Applications of multivariate analysis of variance to repeated measruements experiments. Biometrics 22: 810-828.
7. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA et al (2000a). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38: 313-321.
8. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA et al (2000b). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38: 313-321.
9. Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA et al (2000c). Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience 101: 277-282.
10. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393: 76-79.
11. Fu SS, Partin MR, Snyder A, An LC, Nelson DB, Clothier B et al (2006). Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care 12: 235-243.
12. Ghatan PH, Ingvar M, Eriksson L, Stone-Elander S, Serrander M, Ekberg K et al (1998). Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology (Berlin) 136: 179-189.
13. Gilbert D, McClernon J, Rabinovich N, Sugai C, Plath L, Asgaard G et al (2004). Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob Res 6: 249-267.
14. Haber SN, McFarland NR (1999). The concept of the ventral striatum in nonhuman primates. Ann NY Acad Sci 877: 33-48.
15. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B et al (2004). Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29: 1378-1385.
16. Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B, Svensson TH (1998). Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res 779: 214-225.
17. Hughes J, Hatsukami DK (1998). Errors in using tobacco withdrawal scale. Tob Control 7: 92-93.
18. Hughes JR (2001). Why does smoking so often produce dependence? A somewhat different view. Tob Control 10: 62-64.
19. Hughes JR, Hatsukami D (1986). Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294.
20. Jarvik M, Killen JD, Varady A, Fortmann SP (1993). The favorite cigarette of the day. J Behav Med 16: 413-422.
21. Levin JM, Wald LL, Kaufman MJ, Ross MH, Maas LC, Renshaw PF (1998). T1 effects in sequential dynamic susceptibility contrast experiments. J Magn Reson 130: 292-295.
22. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D (2002). Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph 26: 251-264.
23. Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence: a self- medication hypothesis. Neuropsychopharmacology 18: 135-174.
24. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al (2001). Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21: 1034-1057.
25. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996). High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36: 715-725.
26. Piasecki TM, Fiore MC, Baker TB (1998). Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol 107: 238-251.
27. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ (1994b). Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193: 637-641.
28. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ (1994a). Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193: 637-641.
29. Rorden C, Brett M (2000). Stereotaxic display of brain lesions. Behav Neurol 12: 191-200.
30. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC et al (2003b). PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160: 323-333.
31. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC et al (2003a). PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160: 323-333.
32. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC et al (2003c). PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160: 323-333.
33. Rosen BR, Belliveau J, Buchbinder B, McKinstry RC, Porkka LM, Kennedy DN et al (1991). Contrast agents and cerebral hemodynamics. Magn Reson Med 19: 285-292.
34. Schneider NG, Jarvik ME, Forsythe AB (1984). Nicotine vs placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9: 149-156.
35. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG et al (1998). Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155: 1009-1015.
36. Watkins SS, Koob GF, Markou A (2000). Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2: 19-37.
37. West R, Hajek P, Belcher M (1989). Time course of cigarette withdrawal symptoms while using nicotine gum. Psychopharmacology (Berlin) 99: 143-145.
38. Zubieta J, Lombardi U, Minoshima S, Guthrie S, Ni L, Ohl LE et al (2001). Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry 49: 906-913.
39. Zubieta JK, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S et al (2005). Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162: 567-577.